Transcriptional control of a rRNA promoter of the nodulating symbiont Sinorhizobium meliloti.

FEMS Microbiol Lett

University of Connecticut, Department of Molecular and Cell Biology, 91 N. Eagleville Rd., U-44, Storrs, CT 06269, USA.

Published: September 2003

We constructed a stable, low-copy-number plasmid containing a fusion between a Sinorhizobium meliloti rRNA promoter and gfp(mut3). When transformed into S. meliloti the resulting strain, Rm1021/pKW1, fluoresced in proportion to its growth rate during balanced growth. This strain also showed an unexpected behavior when grown to stationary phase in TY medium: the average cellular fluorescence increased through mid-exponential phase then decreased dramatically. The explanation for this appears to be that transcription from the rRNA promoter was shut off in mid-exponential phase and intracellular Gfp was diluted by continued cell growth.

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0378-1097(03)00603-7DOI Listing

Publication Analysis

Top Keywords

rrna promoter
12
sinorhizobium meliloti
8
mid-exponential phase
8
transcriptional control
4
control rrna
4
promoter nodulating
4
nodulating symbiont
4
symbiont sinorhizobium
4
meliloti constructed
4
constructed stable
4

Similar Publications

Article Synopsis
  • The study focuses on the role of miR-483-5p in regulating the overexpression of IGF2 and H19, which are linked to hepatocellular carcinoma (HCC).
  • miR-483-5p enhances IGF2 and H19 expression by binding to their enhancer, activating transcription, and promoting new interactions between the enhancer and gene promoters through chromatin loops.
  • The research highlights that MED1 is crucial in this process, influencing both chromatin structure and the aggressive behavior of HCC cells, indicating potential targets for therapeutic interventions.
View Article and Find Full Text PDF

NFKB1 as a key player in Tumor biology: from mechanisms to therapeutic implications.

Cell Biol Toxicol

January 2025

Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang , Liaoning Province, China.

NFKB1, a core transcription factor critical in various biological process (BP), is increasingly studied for its role in tumors. This research combines literature reviews, meta-analyses, and bioinformatics to systematically explore NFKB1's involvement in tumor initiation and progression. A unique focus is placed on the NFKB1-94 ATTG promoter polymorphism, highlighting its association with cancer risk across diverse genetic models and ethnic groups, alongside comprehensive analysis of pan-cancer expression patterns and drug sensitivity.

View Article and Find Full Text PDF

Clear cell renal cell carcinoma (ccRCC) is a highly malignant tumor characterized by a significant propensity for recurrence and metastasis. DNA methylation has emerged as a critical epigenetic mechanism with substantial utility in cancer diagnosis. In this study, multi-omics data were utilized to investigate the target genes regulated by the transcription factor MYC-associated zinc finger protein (MAZ) in ccRCC, leading to the identification of thymidine phosphorylase (TYMP) as a gene with notably elevated expression in ccRCC.

View Article and Find Full Text PDF

Apurinic/apyrimidinic (AP) sites are endogenous DNA lesions widespread in human cells. Having no nucleobases, they are noncoding and promutagenic. AP site repair is generally initiated through strand incision by AP endonuclease 1 (APE1).

View Article and Find Full Text PDF

Previous data show that the knockdown of the gene in the MDA-MB-231 cell line leads to the downregulation of gene expression. In addition, and genes are co-expressed and dysregulated in some of the same triple negative breast cancer patient samples. We propose that the co-expression of the two genes is attributed to the MYBL1 transcription factor regulation of the gene.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!